A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This trial investigates pemetrexed and cisplatin followed by pemetrexed and cisplatin in
combination with radiotherapy in participants with locally advanced, non-small cell lung
cancer (NSCLC). The purpose of the study is to assess the antitumor activity as measured by
progression free survival 1 year after start of treatment with study drug.